Retatrutid na advans risach pεptida we dεn stכdi fכ in yכnik aktiviti we involv GLP-1, GIP, εn glukagon rεsεpכta path dεm. as tripl rεsεpכta agonist, i dכn atrak bכku atεnshכn insay mεtabolik risεch, inklud stכdi dεm we riliyt to εnεji bεlε, glukכs dayabεtis, apεtit rεgulεshכn, εn bכdi wet mεkanism. di 60mg spεsifikεshכn de gi risach pipul dεm wan fayn kwantiti fכ labכtכri analisis, pεptida risεch, εn εkspεriεns evalueshכn.
Dɛn de gi dis prɔdak as Risach Yuz Ɔnli (RUO) matirial fɔ sayɛns risach aplikeshɔn dɛn.
